BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Gland Pharma Ltd Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
543245
ISIN Demat
INE068V01023
Book Value (Rs)
656.1222708
NSE Symbol
GLAND
Divident Yield %
0.93
Market Cap
(Rs In Cr.)
35,574
P/E (TTM)
27
EPS (TTM)
79.97
Face Value
(Rs)
1
Back
Gland Pharma consolidated net profit rises 96.57% in the March 2026 quarter
15-May-26   Hrs IST

Net profit of Gland Pharma rose 96.57% to Rs 366.68 crore in the quarter ended March 2026 as against Rs 186.54 crore during the previous quarter ended March 2025. Sales rose 22.31% to Rs 1742.79 crore in the quarter ended March 2026 as against Rs 1424.91 crore during the previous quarter ended March 2025.

For the full year,net profit rose 47.07% to Rs 1027.32 crore in the year ended March 2026 as against Rs 698.53 crore during the previous year ended March 2025. Sales rose 14.50% to Rs 6430.65 crore in the year ended March 2026 as against Rs 5616.50 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales1742.791424.91 22 6430.655616.50 15
OPM %29.4424.39 -25.3422.59 -
PBDT614.46384.09 60 1912.601440.53 33
PBT505.80288.33 75 1488.931062.66 40
NP366.68186.54 97 1027.32698.53 47

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)